Announcement on Initial Share Repurchase by the Company via Call Auction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Initial Share Repurchase by the Company via Call Auction
Filed with SSE · · 2 pages · Chinese
Release
Beijing Hotgen Biotech Co. Ltd. on 6ix
Earlier from Beijing Hotgen Biotech
- Announcement on Early Termination of the Repurchased Shares Sale Plan and the Results of the Sale of Repurchased Shares
- Announcement on Serious Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Capital Increase of Joint Stock Company and Related Party Transactions
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
Later from Beijing Hotgen Biotech
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase
- Announcement on Progress in Repurchasing Shares
- Announcement on Voluntary Disclosure of Obtaining the "Drug Clinical Trial Approval Notice" for Subsidiary’s Innovative Drug SGT003 Injection
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Voluntary Disclosure of Obtaining "Drug Clinical Trial Approval" for New Indication of Subsidiary's Innovative Drug SGC001 Injection
Follow Beijing Hotgen Biotech into a list and get an email when it puts out news.
Follow Beijing Hotgen Biotech